State Street Corporation 13D and 13G filings for Vir Biotechnology, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-10-18 12:29 pm Sale |
2024-09-30 | 13G | Vir Biotechnology, Inc. VIR |
STATE STREET CORP STT |
5,625,533 4.100% |
-1,286,549 (-18.61%) |
Filing |
| 2024-01-24 07:59 am Purchase |
2023-12-31 | 13G | Vir Biotechnology, Inc. VIR |
STATE STREET CORP STT |
6,912,082 5.140% |
6,912,082 (New Position) |
Filing |